Liabilities / Assets
77th percentile
Higher debt load relative to assets than 77% of similar nonprofits.
The Alliance for Benzodiazepine Best Practices
EIN 82-4973519 • Portland, OR
Siviq Scores
Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.
0.08x
Liabilities / Revenue
79th percentile
Higher debt load relative to revenue than 79% of similar nonprofits.
Net Margin
81st percentile
Higher net margin than 81% of similar nonprofits.
Top Officer Pay
81st percentile
Higher top officer pay than 81% of similar nonprofits.
Top officer pay equals 0.0% of source-year revenue.
Asset Growth
87th percentile
Faster asset growth than 87% of similar nonprofits.
Revenue Growth
73rd percentile
Faster revenue growth than 73% of similar nonprofits.
Balance Sheet
Assets
Up$61,781
Up $5,253 (+9.3%) from 2020
Liabilities
Up$12,000
Up $12,000 from 2020
Net Assets
Down$49,781
Down $6,747 (-12%) from 2020
Revenue
Down$109,326
Down $164,060 (-60%) from 2020
Expenses
Down$77,556
Down $139,580 (-64%) from 2020
Net Income
Down$31,770
Down $24,480 (-44%) from 2020
Trend Graphs
Filings
Most recent year
2023 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $61,781
- Liabilities
- $12,000
- Net assets
- $49,781
- Revenue
- $109,326
- Expenses
- $77,556
- Net income
- $31,770
Latest Filing Detail
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2023 to Dec 31, 2023
Mission and Program Overview
Mission
Our mission is to reduce the harm caused by benzodiazepines and Z-drugs by making evidence-based improvements to the prescribing of these medications.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.